Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lauer

Showing results (321-330 of 604) with videos related to

Pageof 61
Sort By:
Gene Therapy|September 3, 2010
Direct and long-term detection of gene doping in conventional blood samplesT Beiter, M Zimmermann, A Fragasso, et al.
Annals of Transplantation|January 16, 2019
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First ExperiencePhilipp Horvath, Can Yurttas, Florian Struller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2003
Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathwayMartin H Deininger, Wolfgang A Wybranietz, Florian T C Graepler, et al.
Journal of Virological Methods|March 1, 2003
Cell cycle independent infection and gene transfer by recombinant Sendai virusesSorin Armeanu, Guy Ungerechts, Christian Bernloehr, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug usersArthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
Viruses|February 27, 2026
Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734Fiona D Nitschke, Julia Beil, Irina Smirnow, et al.
Virology Journal|April 19, 2015
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohortChristoph R Werner, Carolin Franz, Daniel P Egetemeyr, et al.
Plos One|November 23, 2013
Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2012
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy dataChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
BMC Cancer|December 5, 2019
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapyChihab Klose, Susanne Berchtold, Marina Schmidt, et al.
Pageof 61

Showing results (321-330 of 604) with videos related to

Sort By:
Pageof 61
Gene Therapy|September 3, 2010
Direct and long-term detection of gene doping in conventional blood samplesT Beiter, M Zimmermann, A Fragasso, et al.
Annals of Transplantation|January 16, 2019
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First ExperiencePhilipp Horvath, Can Yurttas, Florian Struller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2003
Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathwayMartin H Deininger, Wolfgang A Wybranietz, Florian T C Graepler, et al.
Journal of Virological Methods|March 1, 2003
Cell cycle independent infection and gene transfer by recombinant Sendai virusesSorin Armeanu, Guy Ungerechts, Christian Bernloehr, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug usersArthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
Viruses|February 27, 2026
Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734Fiona D Nitschke, Julia Beil, Irina Smirnow, et al.
Virology Journal|April 19, 2015
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohortChristoph R Werner, Carolin Franz, Daniel P Egetemeyr, et al.
Plos One|November 23, 2013
Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2012
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy dataChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
BMC Cancer|December 5, 2019
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapyChihab Klose, Susanne Berchtold, Marina Schmidt, et al.
Pageof 61